慢性术后疼痛和过渡性疼痛服务:强调欧洲观点的叙事综述
Eleni Moka1, José Alejandro Aguirre2, Axel R Sauter3
1Anaesthesiology Department, Creta Interclinic Hospital, Hellenic Healthcare Group (HHG), Heraklion, Crete, Greece mokaeleni@hotmail.com.
Regional anesthesia and pain medicine
|February 5, 2025
概括
慢性术后疼痛 (CPSP) 影响了许多患者,造成了痛苦和医疗负担. 过渡性疼痛服务和生物标志物显示出更好的预测和管理这种复杂的条件的希望.
科学领域:
- 疼痛医学 医学 疼痛医学
- 外科手术的结果
- 医疗保健管理的管理
背景情况:
- 慢性术后疼痛 (CPSP) 是一个重要的全球健康问题,影响患者的生活质量和医疗保健系统.
- 被定义为术后持续超过3个月的疼痛,CPSP被认为是一个独立的实体 (ICD-11),但仍然普遍存在 (5%-85%的患者).
- 对CPSP的高风险因素包括手术类型,神经损伤,急性神经病痛和心理社会因素,需要改进预防策略.
研究的目的:
- 审查当前对慢性术后疼痛 (CPSP) 的理解和管理.
- 探索CPSP预防,预测和治疗的新兴策略.
- 突出过渡性疼痛服务 (TPS) 和疼痛生物标志物的作用.
主要方法:
- 对CPSP的当前疼痛管理策略的文献综述.
- 从急性疼痛机制过渡到慢性疼痛机制的分析.
- 检查TPS和疼痛生物标志物对CPSP管理的潜力.
主要成果:
- 现有的疼痛管理策略 (多模式治疗,区域麻醉) 在预防CPSP方面有效性有限.
- 过渡性疼痛服务 (TPSs) 提供了一种多学科的方法来管理CPSP和减少阿片类药物.
- 对于改善CPSP预测和有针对性的干预措施的疼痛生物标志物越来越感兴趣.
结论:
- CPSP需要超越当前模式的全面管理策略.
- 过渡性疼痛服务 (TPS) 和疼痛生物标志物代表了未来CPSP护理的有希望的途径.
- 需要进一步的大规模研究,以整合增强CPSP预测和预防的因素.
相关概念视频
Analgesia and Pain Management
443
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
443
Chronic Pancreatitis II: Collaborative Care
60
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
60
Opioid Analgesics: Synthetic and Semisynthetic Opioids
211
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
211


